Casey Alexander, Nicholas J Bush, John K Neubert, Michael Robinson, Jeff Boissoneault
{"title":"Expectancy of alcohol analgesia moderates perception of pain relief following acute alcohol intake.","authors":"Casey Alexander, Nicholas J Bush, John K Neubert, Michael Robinson, Jeff Boissoneault","doi":"10.1037/pha0000664","DOIUrl":null,"url":null,"abstract":"<p><p>Although laboratory studies indicate alcohol reduces pain intensity and increases pain threshold, these effects likely do not completely explain perceived pain relief from alcohol intake. In this study, we tested expectancy of alcohol analgesia (EAA) as a moderator of subjective pain relief following oral alcohol challenge in individuals with and without chronic orofacial pain. Social drinkers (<i>N</i> = 48; 19 chronic pain; 29 pain-free controls) completed two testing sessions: alcohol administration (BrAC: 0.08 g/dL) and placebo. Alcohol expectancy (AE) was assessed using the EAA questionnaire and two 100-mm Visual Analogue Scales (VASs) regarding strength of belief that alcohol provides pain relief (AE VAS 1) or reduces pain sensitivity (AE VAS 2). Participants completed quantitative sensory testing (QST) involving application of pressure to the masseter insertion. Pain threshold (lbf; three repetitions) and pain intensity (4, 5, and 6 lbf; three repetitions each; 100-mm VAS) were collected. After each stimulus, participants rated perceived pain relief due to consumption of the study beverage (0-100 VAS). Higher EAA and AE VAS 1 ratings were associated with stronger perceived relief in the alcohol, but not placebo, condition. However, expectancy specifically related to reduction in pain sensitivity (AE VAS 2) was not associated with relief. Additionally, changes in pain threshold and intensity were not significantly correlated with perceived relief. Taken together, results suggest expectancy that alcohol provides pain relief is an important determinant of its negative reinforcing effects. Future studies should investigate challenging these expectancies as a means of reducing alcohol-related risk in people with pain. (PsycInfo Database Record (c) 2024 APA, all rights reserved).</p>","PeriodicalId":12089,"journal":{"name":"Experimental and clinical psychopharmacology","volume":null,"pages":null},"PeriodicalIF":2.4000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10749982/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental and clinical psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1037/pha0000664","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/6/26 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Although laboratory studies indicate alcohol reduces pain intensity and increases pain threshold, these effects likely do not completely explain perceived pain relief from alcohol intake. In this study, we tested expectancy of alcohol analgesia (EAA) as a moderator of subjective pain relief following oral alcohol challenge in individuals with and without chronic orofacial pain. Social drinkers (N = 48; 19 chronic pain; 29 pain-free controls) completed two testing sessions: alcohol administration (BrAC: 0.08 g/dL) and placebo. Alcohol expectancy (AE) was assessed using the EAA questionnaire and two 100-mm Visual Analogue Scales (VASs) regarding strength of belief that alcohol provides pain relief (AE VAS 1) or reduces pain sensitivity (AE VAS 2). Participants completed quantitative sensory testing (QST) involving application of pressure to the masseter insertion. Pain threshold (lbf; three repetitions) and pain intensity (4, 5, and 6 lbf; three repetitions each; 100-mm VAS) were collected. After each stimulus, participants rated perceived pain relief due to consumption of the study beverage (0-100 VAS). Higher EAA and AE VAS 1 ratings were associated with stronger perceived relief in the alcohol, but not placebo, condition. However, expectancy specifically related to reduction in pain sensitivity (AE VAS 2) was not associated with relief. Additionally, changes in pain threshold and intensity were not significantly correlated with perceived relief. Taken together, results suggest expectancy that alcohol provides pain relief is an important determinant of its negative reinforcing effects. Future studies should investigate challenging these expectancies as a means of reducing alcohol-related risk in people with pain. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
尽管实验室研究表明,酒精可以降低疼痛强度并提高疼痛阈值,但这些影响可能并不能完全解释饮酒后的疼痛缓解。在这项研究中,我们测试了酒精镇痛(EAA)作为口服酒精刺激后主观疼痛缓解的调节因子的预期值,用于患有和不患有慢性口腔面部疼痛的个体。社交饮酒者(N=48;19名慢性疼痛患者;29名无疼痛对照者)完成了两次测试:酒精给药(BrAC:0.08g/dL)和安慰剂。使用EAA问卷和两个100 mm视觉模拟量表(VAS)评估酒精预期(AE),评估酒精提供疼痛缓解(AE VAS 1)或降低疼痛敏感性(AE VAS 2)的信念强度。参与者完成了定量感觉测试(QST),包括对咬肌插入施加压力。收集疼痛阈值(lbf;三次重复)和疼痛强度(4、5和6 lbf;每次重复三次;100 mm VAS)。每次刺激后,参与者对因饮用研究饮料而感知到的疼痛缓解进行评分(0-100 VAS)。较高的EAA和AE VAS 1评分与更强的酒精缓解相关,但与安慰剂无关。然而,与疼痛敏感性降低特别相关的预期(AE VAS 2)与缓解无关。此外,疼痛阈值和强度的变化与感知缓解没有显著相关性。总之,研究结果表明,期望酒精能缓解疼痛是其负面强化作用的重要决定因素。未来的研究应该调查挑战这些预期,作为降低疼痛患者与酒精相关风险的一种手段。(PsycInfo数据库记录(c)2023 APA,保留所有权利)。
期刊介绍:
Experimental and Clinical Psychopharmacology publishes advances in translational and interdisciplinary research on psychopharmacology, broadly defined, and/or substance abuse.